CC
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics |  | 2025 | 26 | 19 | ||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology |  | 2025 | 24 | 0 | ||
| Corticosteroid therapy in older adults with cancer : Expert recommendations from a task force of the International Society of Geriatric Oncology | Journal of geriatric oncology | | 2024 | 12 | 0 | ||
| Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study | Cancers | | 2024 | 40 | 62 | ||
| A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial | PloS one | | 2024 | 58 | 20 | ||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | 2023 | 128 | 116 | ||
| Infant exposure to Fluvoxamine through placenta and human milk : a case series - A contribution from the ConcePTION project | Frontiers in psychiatry | | 2023 | 43 | 24 | ||
| Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study | Cancers | | 2023 | 141 | 64 | ||
| From personalized to precision medicine in oncology: A model-based dosing approach to optimize achievement of imatinib target exposure | Pharmaceutics | | 2023 | 109 | 48 | ||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | 2023 | 97 | 83 | ||
| Parametric and Nonparametric Methods in Population Pharmacokinetics: Experts' Discussion on Use, Strengths, and Limitations | Journal of clinical pharmacology | | 2022 | 64 | 0 | ||
| Interventions to Support Adherence to Oral Anticancer Therapies: Research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland | Supportive care in cancer | | 2022 | 253 | 132 | ||
| Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation | The journal of antimicrobial chemotherapy | | 2022 | 88 | 0 | ||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | | 2022 | 136 | 129 | ||
| Medication adherence evaluated through electronic monitors during the 2020 COVID-19 pandemic lockdown in Switzerland: a longitudinal analysis | Patient preference and adherence | | 2022 | 134 | 58 | ||
| Population pharmacokinetics of palbociclib and its correlation with clinical efficacy and safety in patients with advanced breast cancer | Pharmaceutics | | 2022 | 111 | 81 | ||
| Protocols for cognitive enhancement. a user manual for brain health services — part 5 of 6 | Alzheimer's research & therapy | | 2021 | 137 | 87 | ||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | | 2021 | 143 | 0 | ||
| Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review | European journal of clinical pharmacology | | 2021 | 70 | 42 | ||
| Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2 | European journal of clinical pharmacology | | 2021 | 72 | 45 | ||
| Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services — part 6 of 6 | Alzheimer's research & therapy | | 2021 | 115 | 51 | ||
| Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review | Journal of clinical pharmacy and therapeutics | | 2021 | 57 | 0 | ||
| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data | JMIR research protocols | | 2021 | 202 | 147 | ||
| Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration | European journal of clinical pharmacology | | 2021 | 70 | 0 | ||
| Cross-cultural adaptation and psychometric validation of the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire in French | Research in social and administrative pharmacy | | 2021 | 80 | 0 | ||
| The steps to therapeutic drug monitoring: A structured approach illustrated with imatinib | Frontiers in Pharmacology | | 2020 | 331 | 212 | ||
| A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk | British Journal of Clinical Pharmacology | | 2020 | 423 | 2 | ||
| Population pharmacokinetics of erlotinib in patients with non-small cell lung cancer: Its application for individualized dosing regimens in older patients | Clinical Therapeutics | | 2020 | 317 | 1 | ||
| Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy | Open Forum Infectious Diseases | | 2020 | 205 | 101 | ||
| Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: A critical review | Therapeutic Drug Monitoring | | 2020 | 226 | 1 | ||
| Contribution of Genetic Background and Data Collection on Adverse Events of Anti–human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate | Clinical Infectious Diseases | | 2020 | 261 | 0 | ||
| Validation and Clinical Application of a Multiplex High Performance Liquid Chromatography - Tandem Mass Spectrometry Assay for the Monitoring of Plasma Concentrations of 12 Antibiotics in Patients with Severe Bacterial Infections | Journal of Chromatography. B | | 2020 | 287 | 164 | ||
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | | 2019 | 465 | 2 | ||
| Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherence | The journal of antimicrobial chemotherapy | | 2019 | 72 | 0 | ||
| Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an update | Expert Opinion on Drug Safety | | 2019 | 259 | 0 | ||
| Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial | PLOS ONE | | 2019 | 213 | 87 | ||
| Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections | Journal of antimicrobial chemotherapy | | 2018 | 44 | 130 | ||
| Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry | Journal of Chromatography. B | | 2018 | 251 | 0 | ||
| Effect of adherence on pharmacokinetic/pharmacodynamic relationships of oral targeted anticancer drugs | Clinical Pharmacokinetics | | 2018 | 282 | 0 | ||
| Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations | Antimicrobial Agents and Chemotherapy | | 2018 | 426 | 0 | ||
| Bon usage des antidépresseurs ISRS durant la grossesse – le défi de l'évaluation de la balance bénéfice-risque | Revue médicale suisse | | 2016 | 662 | 5 | ||
| Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates | The Journal Of Clinical Pharmacology | | 2016 | 453 | 1 | ||
| Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance | British journal of clinical pharmacology | | 2014 | 546 | 0 | ||
| Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model | The journal of antimicrobial chemotherapy | | 2013 | 560 | 0 | ||
| Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals | Pharmacogenetics and genomics | | 2013 | 609 | 0 | ||
| ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir | Pharmacogenetics and genomics | | 2010 | 655 | 0 |
